SBIR/STTR Research Award
SBIR TOPIC 255, PHASE II: SYNTHETIC VACCINES AGAINST PROSTATE CANCER
Award amount
$1,483,094Program and phase
SBIR · Phase IIAward year
2011Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MEDIGEN, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- MGLJHKGKWBL3
- Solicitation number
- Not reported
- Topic code
- NCI
Research abstract
This Phase II, SBIR contract is for the advanced vaccine efficacy studies, which involve TRAMP tumor challenge of vaccinated PSA+ transgenic mice. Engineered for increased immunogenicity PSA variants will be delivered and expressed in PSA+ mice using novelvector VLP (vVLP_ vaccine platform. The latter represent non-replicating virus-like particles configured to encapsidate expression vector for in vivo delivery and expression of engineered PSA genes.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel Chikungunya vaccine with rearranged genome
- Multivalent emergency vaccine against pandemic influenza
- Novel DNA Launched Attenuated Vaccine for VEE Virus SBIR Phase II
- Polyvalent Vaccines to Protect Poultry from Avian Influenza
- Novel DNA-Launched Attenuated Vaccine for VEE Virus
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
10 SBIR/STTR records share this UEI (2009–2020). Reported award amounts total $5,064,333. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Agriculture